[1] Barabutis N,Schally AV. Growth hormone-releasing hormone:extrapituitary effects in physiology and pathology[J].Cell Cycle,2010,9(20):4110-4116.
[2] Mackrides N,Ganjei-Azar P,Perez R,et al.GHRH receptor expression in malignant mixed mullerian tumors:a potentially targetable biopredictor[J].Int J Gynecol Pathol,2016,35(2):142-146.
[3] Theophanous E,Petraki C,Scorilas A,et al.The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer[J].Mol Med,2009,15(7/8):242-247.
[4] Dioufa N,Farmaki E,Schally AV,et al.Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas[J].Horm Cancer,2012,3(4):172-180.
[5] Klukovits A,Schally AV,Szalontay L,et al.Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers[J].Cancer,2012,118(3):670-680.
[6] Rekasi Z,Czompoly T,Schally AV,et al.Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers[J].Proc Natl Acad Sci U S A,2000,97(19):10561-10566.
[7] Toller GL,Horvath JE,Schally AV,et al.Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors[J].Proc Natl Acad Sci U S A,2004,101(42):15160-15165.
[8] Kiaris H,Chatzistamou I,Papavassiliou AG,et al.Growth hormone-releasing hormone:not only a neurohormone[J].Trends Endocrinol Metab,2011,22(8):311-317.
[9] Barabutis N,Tsellou E,Schally AV,et al.Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor[J].Proc Natl Acad Sci U S A,2007,104(13):5575-5579.
[10] Mezey G,Treszl A,Schally AV,et al.Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone,pituitary-type growth hormone-releasing hormone receptor,its splicing variant receptors,EGF receptor and PTEN genes[J].J Cancer Res Clin Oncol,2014,140(10):1641-1649.
[11] Fahrenholtz CD,Rick FG,Garcia MI,et al.Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer[J].Proc Natl Acad Sci U S A,2014,111(3):1084-1089.
[12] Barabutis N,Siejka A,Schally AV,et al.Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor[J].J Mol Endocrinol,2010,44(2):127-134.
[13] Kiaris H,Chatzistamou I,Schally AV,et al.Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor[J].Proc Natl Acad Sci U S A,2003,100(16):9512-9517.
[14] Schally AV,Perez R,Block NL,et al.Potentiating effects of GHRH analogs on the response to chemotherapy[J].Cell Cycle,2015,14(5):699-704.
[15] Schally AV,Varga JL.Antagonists of growth hormone-releasing hormone in oncology[J].Comb Chem High Throughput Screen,2006,9(3):163-170. |